Skip to search formSkip to main contentSkip to account menu

HIVAC-1e

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1999
Review
1999
  • R. Zheng
  • Current opinion in molecular therapeutics (Print)
  • 1999
  • Corpus ID: 33030077
Bristol-Myers Squibb is developing a vaccine, HIVAC-1e, comprised of a recombinant vaccinia virus expressing the HIV-1 gp160… 
1995
1995
Cytotoxic T lymphocytes (CTL) play an important role in the immune response to viral infection by recognizing and destroying… 
1994
1994
Priming with a live recombinant vector followed by subunit boosting is a promising strategy for human immunodeficiency virus (HIV… 
Highly Cited
1993
Highly Cited
1993
Sera from 11 volunteers immunized with a recombinant HIV-1 gp160-expressing vaccinia virus (HIVAC-1e; Oncogen/Bristol-Myers… 
Highly Cited
1992
Highly Cited
1992
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) gp160 recombinant vaccinia virus (HIVAC-1e…